Pomalyst (pomalidomide capsules) — Cigna
Primary Central Nervous System Lymphoma
Initial criteria
- Patient has relapsed or refractory disease OR According to the prescriber, the patient is not a candidate for high-dose methotrexate OR Patient has had intolerance to high-dose methotrexate
Approval duration
1 year